CDK1 Phosphorylates KAT8 at Ser348 to Stabilize the MSL Complex and Promote H4K16 Acetylation in Non-Small Cell Lung Cancer
Cells · 2026
DOI: 10.3390/cells15100897 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Jinmeng Chu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Jilin University, Changchun 130012, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, CDC2 Protein Kinase, Histones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Cyclin-dependent kinase 1 (CDK1) is frequently upregulated in multiple cancers and plays a central role in cell cycle progression and tumorigenesis. However, whether CDK1 directly regulates the histone acetyltransferase KAT8 (also known as MOF) in non-small cell lung cancer (NSCLC) remains unclear. Here, we identify CDK1 as a kinase that directly interacts with and phosphorylates KAT8 at serine 348 (S348) and threonine 418 (T418). Mechanistically, CDK1-mediated phosphorylation, particularly at S348, enhances the interaction between KAT8 and MSL1, thereby stabilizing the MSL complex and promoting KAT8-dependent acetylation of histone H4 at lysine 16 (H4K16). Functionally, the phosphorylation-deficient mutant KAT8-S348A exhibits impaired MSL complex assembly, reduced H4K16 acetylation, and decreased NSCLC cell proliferation both in vitro and in vivo. Pharmacological inhibition of CDK1 using RO-3306 suppresses KAT8 phosphorylation and H4K16 acetylation, leading to significant tumor growth inhibition. Notably, this effect is partially rescued by re-expression of wild-type KAT8 but not by the S348A mutant, supporting a phosphorylation-dependent mechanism. Collectively, these findings define a CDK1–KAT8 signaling axis that promotes NSCLC proliferation through epigenetic regulation and suggest that targeting CDK1-dependent KAT8 phosphorylation may represent a potential therapeutic strategy for lung cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Jilin University, Changchun 130012, China.
ORCID-Profile: Jingji Jin
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Chu, J., Zhao, Q., Ye, H., Li, M., Wang, Y., Xu, T., Cai, Y., & Jin, J. (2026). CDK1 Phosphorylates KAT8 at Ser348 to Stabilize the MSL Complex and Promote H4K16 Acetylation in Non-Small Cell Lung Cancer. Cells. https://doi.org/10.3390/cells15100897
Vancouver
Chu J, Zhao Q, Ye H, Li M, Wang Y, Xu T, et al. CDK1 Phosphorylates KAT8 at Ser348 to Stabilize the MSL Complex and Promote H4K16 Acetylation in Non-Small Cell Lung Cancer. Cells. 2026. doi:10.3390/cells15100897
BibTeX
@article{Chu2026,
author = {Chu, Jinmeng and Zhao, Qingzhi and Ye, Hui and Li, Meixu and Wang, Yizhen and Xu, Tiantian and Cai, Yong and Jin, Jingji},
title = {CDK1 Phosphorylates KAT8 at Ser348 to Stabilize the MSL Complex and Promote H4K16 Acetylation in Non-Small Cell Lung Cancer},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15100897}
}
EUVIMED